Oncogene. 36(25):3515–3527, JUN 2017

DOI: 10.1038/onc.2016.518

,  

PMID: 28166194

Issn Print: 0950-9232

Publication Date: 2017/06/01


Share this on facebook   Share this on Twitter   Share this on LinkedIn   Email this article  



Print

Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ

M Escoll;R Gargini;A Cuadrado;I Anton;F Wandosell;

+ Author Information


    loading  Checking for direct PDF access through Ovid

Abstract

Wild-type p53 (wtp53) is described as a tumour suppressor gene; mutations in this gene occur in many human cancers and promote oncogenic capacity. Here, we establish that the oncogenic activity of mutant p53 (mtp53) is driven by the WASP-interacting protein (WIP). WIP knockdown from mtp53-expressing glioblastoma and breast cancer cells (BCC) greatly reduced proliferation and growth capacity of cancer stem cell (CSC)-like cells and decreased CSC-like markers (CD133, CD44 or YAP/TAZ). mtp53 overexpression in human astrocytes enhanced their proliferative capacity in suspension culture and increased expression of CSC markers and WIP. WIP knockdown compromised tumour glioblastoma and BCC growth capacity in vivo. We show that WIP is phosphorylated by AKT2 and is regulated by mtp53/p63 through enhancement of PI3K/AKT2-mediated integrin/receptor recycling pathways. WIP regulates this oncogenic pathway by controlling YAP/TAZ stability. We thus establish a new CSC signalling pathway downstream of mtp53 in which AKT2 regulates WIP and controls YAP/TAZ stability.

Related Topics

        loading  Loading Related Articles